We are live on ! Find out more
IMVT icon

Immunovant
IMVT

133 hedge funds and large institutions have $980M invested in Immunovant in 2022 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 53 increasing their positions, 28 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

3,504% more call options, than puts

Call options by funds: $8.87M | Put options by funds: $246K

400% more funds holding in top 10

Funds holding in top 10: 1 → 5 (+4)

312% more capital invested

Capital invested by funds: $238M → $980M (+$742M)

117% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 18

89% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 28

19% more funds holding

Funds holding: 112 → 133 (+21)

7.16% more ownership

Funds ownership: 36.59% → 43.75% (+7.2%)

Holders
133
Holders Change
+21
Holders Change %
+18.75%
% of All Funds
2.14%
Holding in Top 10
5
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+400%
% of All Funds
0.08%
New
39
Increased
53
Reduced
28
Closed
18
Calls
$8.87M
Puts
$246K
Net Calls
+$8.62M
Net Calls Change
+$6.06M

Top Buyers

1
LGM
Logos Global Management
California
+$39.7M
2
BI
BVF Inc
California
+$32.2M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$31.3M
4
State Street
State Street
Massachusetts
+$28.1M
5
CAC
Cowen and Company
New York
+$15.7M

Top Sellers

1
AGM
Alpine Global Management
New York
-$35.9M
2
EAM
Eventide Asset Management
Massachusetts
-$21.1M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$19.3M
4
WP
Woodline Partners
California
-$11.9M
5
OCA
Octagon Capital Advisors
New York
-$3.23M
Name Holding Trade Value Shares
Change 		Change in
Stake
Swiss National Bank
51
Swiss National Bank
Switzerland
$1.66M -$20.1K -1,600 -2%
AA
52
ALPS Advisors
Colorado
$1.55M +$301K +23,896 +38%
CSS
53
Cubist Systematic Strategies
Connecticut
$1.52M +$642K +51,007 +148%
Millennium Management
54
Millennium Management
New York
$1.46M -$2.05M -162,816 -66%
AllianceBernstein
55
AllianceBernstein
Tennessee
$1.43M -$66.7K -5,300 -6%
TI
56
Trexquant Investment
Connecticut
$1.37M +$974K +77,392 New
VRS
57
Virginia Retirement Systems
Virginia
$1.26M -$473K -37,600 -35%
WMSA
58
Weiss Multi-Strategy Advisers
New York
$1.24M +$881K +70,006 New
RhumbLine Advisers
59
RhumbLine Advisers
Massachusetts
$1.24M +$93.9K +7,460 +12%
SPC
60
Sigma Planning Corp
Michigan
$983K +$698K +55,400 New
California State Teachers Retirement System (CalSTRS)
61
California State Teachers Retirement System (CalSTRS)
California
$912K +$6.45K +512 +1%
JP Morgan Chase
62
JP Morgan Chase
New York
$895K -$1.42M -112,794 -69%
CS
63
Credit Suisse
Switzerland
$868K +$109K +8,632 +21%
HSBC Holdings
64
HSBC Holdings
United Kingdom
$862K -$1M -79,697 -62%
State of Wisconsin Investment Board
65
State of Wisconsin Investment Board
Wisconsin
$838K -$2.07M -164,416 -78%
PNC Financial Services Group
66
PNC Financial Services Group
Pennsylvania
$809K – – –
UBS AM
67
UBS AM
Illinois
$777K +$80.7K +6,409 +17%
Federated Hermes
68
Federated Hermes
Pennsylvania
$756K +$412K +32,708 +332%
JAM
69
Jupiter Asset Management
United Kingdom
$745K +$530K +42,082 New
MAM
70
Martingale Asset Management
Massachusetts
$705K -$383K -30,428 -43%
Marshall Wace
71
Marshall Wace
United Kingdom
$691K +$490K +38,953 New
SO
72
STRS Ohio
Ohio
$639K +$112K +8,900 +33%
Squarepoint
73
Squarepoint
New York
$620K +$440K +34,952 New
DekaBank Deutsche Girozentrale
74
DekaBank Deutsche Girozentrale
Germany
$568K – – –
Deutsche Bank
75
Deutsche Bank
Germany
$567K +$67.8K +5,381 +20%
1 2
3
4 5

IMVT Hedge Fund Activity: Q4 2022 in Review

133 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Immunovant (IMVT) for Q4 2022, worth a combined $980M — up 312% from $238M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new IMVT positions and 18 closed out — a net gain of 21 holders — while 53 added to existing stakes and 28 trimmed.

The largest buyer was Logos Global Management, opening a new position worth an estimated $39.7M. The largest seller was Alpine Global Management, cutting an estimated $35.9M.

  • 133 institutional investors held Immunovant (IMVT) as of Q4 2022, up from 112 in Q3 2022.
  • Funds reported $980M of Immunovant stock for Q4 2022, up 312% quarter-over-quarter.
  • 39 funds opened new Immunovant positions in Q4 2022 and 18 closed out, a net change of +21 holders.
  • The largest Immunovant buyer in Q4 2022 was Logos Global Management, an estimated $39.7M added.
  • The largest Immunovant seller in Q4 2022 was Alpine Global Management, an estimated $35.9M sold.

Based on aggregated 13F filings for Q4 2022.